S&P 500   2,986.20 (-0.39%)
DOW   26,770.20 (-0.95%)
QQQ   191.69 (-0.96%)
AAPL   236.41 (+0.48%)
FB   185.85 (-2.38%)
MSFT   137.41 (-1.63%)
GOOGL   1,244.41 (-0.67%)
AMZN   1,757.51 (-1.68%)
CGC   20.21 (-2.65%)
NVDA   190.49 (-1.96%)
MU   43.47 (-4.46%)
BABA   169.13 (-4.37%)
GE   8.96 (-0.88%)
TSLA   256.95 (-1.92%)
AMD   30.97 (-0.55%)
T   38.47 (+1.75%)
F   9.29 (+1.98%)
ACB   3.68 (-5.40%)
PRI   123.53 (-0.44%)
NFLX   275.30 (-6.15%)
BAC   30.35 (+0.30%)
GILD   64.91 (-0.49%)
DIS   130.89 (-1.12%)
S&P 500   2,986.20 (-0.39%)
DOW   26,770.20 (-0.95%)
QQQ   191.69 (-0.96%)
AAPL   236.41 (+0.48%)
FB   185.85 (-2.38%)
MSFT   137.41 (-1.63%)
GOOGL   1,244.41 (-0.67%)
AMZN   1,757.51 (-1.68%)
CGC   20.21 (-2.65%)
NVDA   190.49 (-1.96%)
MU   43.47 (-4.46%)
BABA   169.13 (-4.37%)
GE   8.96 (-0.88%)
TSLA   256.95 (-1.92%)
AMD   30.97 (-0.55%)
T   38.47 (+1.75%)
F   9.29 (+1.98%)
ACB   3.68 (-5.40%)
PRI   123.53 (-0.44%)
NFLX   275.30 (-6.15%)
BAC   30.35 (+0.30%)
GILD   64.91 (-0.49%)
DIS   130.89 (-1.12%)
Log in

Urogen Pharma Price Target & Analyst Ratings (NASDAQ:URGN)

$22.32
-0.09 (-0.40 %)
(As of 10/18/2019 04:00 PM ET)
Today's Range
$22.09
Now: $22.32
$22.79
50-Day Range
$20.92
MA: $28.76
$36.47
52-Week Range
$20.72
Now: $22.32
$55.49
Volume133,500 shs
Average Volume208,923 shs
Market Capitalization$466.42 million
P/E RatioN/A
Dividend YieldN/A
Beta1.14

Analyst Ratings

Urogen Pharma (NASDAQ:URGN) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
8 Wall Street analysts have issued ratings and price targets for Urogen Pharma in the last 12 months. Their average twelve-month price target is $61.57, suggesting that the stock has a possible upside of 175.86%. The high price target for URGN is $77.00 and the low price target for URGN is $41.00. There are currently 2 hold ratings and 6 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.752.752.753.00
Ratings Breakdown: 0 Sell Rating(s)
2 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $61.57$61.86$61.86$68.40
Price Target Upside: 175.86% upside77.44% upside77.44% upside79.39% upside

Urogen Pharma (NASDAQ:URGN) Consensus Price Target History

Urogen Pharma (NASDAQ:URGN) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
9/24/2019CowenReiterated RatingBuyMedium
9/24/2019Stifel NicolausReiterated RatingBuy$61.00High
5/30/2019JPMorgan Chase & Co.Initiated CoverageNeutral$41.00Medium
5/29/2019Goldman Sachs GroupInitiated CoverageNeutral ➝ Neutral$50.00 ➝ $50.00High
5/28/2019HC WainwrightSet Price TargetBuy$75.00High
3/19/2019OppenheimerReiterated RatingBuyLow
3/1/2019Raymond JamesSet Price TargetBuy$57.00Low
11/8/2018Jefferies Financial GroupInitiated CoverageBuy$77.00High
4/4/2018UBS GroupUpgradeMarket Perform ➝ OutperformHigh
3/16/2018LADENBURG THALM/SH SHReiterated RatingBuy ➝ Buy$65.00High
11/15/2017CIBCReiterated RatingOutperform ➝ Outperform$32.00 ➝ $51.00N/A
(Data available from 10/18/2017 forward)
This page was last updated on 10/18/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel